13,348
Views
173
CrossRef citations to date
0
Altmetric
Review Article

Medicinal significance of benzothiazole scaffold: an insight view

, , , &
Pages 240-266 | Received 22 May 2012, Accepted 09 Aug 2012, Published online: 03 Oct 2012

References

  • Chatrabhuji PM, Nimavat KS, Vyas KB, Undavia NK. Synthesis and antimicrobial activity of some 2 -aryl-3-[(4-methyl cinnamoyl amino)-4-oxo-thiazolidines with synthesis and antimicrobial activity of some 2(4-hydroxyphenyl)-3-[(4-methyl cinnamoyl amino)-4-oxo-thiazolidines. RJPBCS 2010;1:451–455.
  • Londhe BS, Pratap UR, Mali JR, Mane RA. Synthesis of 2-Arylbenzothiazoles catalyzed by biomimetic catalyst β-cyclodextrin. Bull Korean Chem Soc 2010;31:2329–2332.
  • Evindar G, Batey RA. Parallel synthesis of a library of benzoxazoles and benzothiazoles using ligand-accelerated copper-catalyzed cyclizations of ortho-halobenzanilides. J Org Chem 2006;71:1802–1808.
  • Tang J, Wu LL, Huang X. Convenient solid-phase synthesis of benzothiazole derivatives. Chin Chem Lett 2003;14:885–886.
  • Malik JK, Manvi FV, Nanjwade BK, Singh S, Purohit P. Review of the 2-amino substituted benzothiazoles: Different methods of the synthesis. Der Pharmacia Lett 2010;2:347–359.
  • Prabhu PP, Pande S, Shastry CS. Synthesis and biological evaluation of schiff’s bases of some new benzothiazole derivatives as antimicrobial agents. IJCRGG 2011;3:185–191.
  • Priyanka, Sharma NK, Jha KK. Benzothiazole: The molecule of diverse biological activities. Int J Curr Pharm Res 2010;2:1–6.
  • Muttu CT, Bhanushali MD, Hipparagi SM, Tikare VP, Karigar A. Microwave assisted synthesis and evaluation of some fluoro chloro 2-N-(substituted Schiff’s bases)aminobenzothiazoles derivatives for their antiinfllamatory activity. IJRAP 2010;1:522–528.
  • Yadav PS, Devprakash, Senthilkumar GP. Benzothiazole: Different methods of synthesis and diverse biological activities. Int J Pharm Sci Drug Res 2011;3:1–7.
  • Rey V, Soria-Castro SM, Arguello JE, Penenory AB. Photochemical cyclization of thioformanilides by chloranil: An approach to 2-substituted benzothiazoles. Tetrahedron Lett 2009;50:4720–4723.
  • Barot HK, Mallika G, Sutariya BB, Shukla J, Nargund LVG. Synthesis of nitrogen mustards of fluoro-benzothiazoles of pharmacological interest. RJPBS 2010;1:124–129.
  • Guo HY, Li JC, Shang YL. A simple and efficient synthesis of 2-substituted benzothiazoles catalyzed by H2O2/HCl. Chin Chem Lett 2009;20:1408–1410.
  • Jaseer EA, Prasad DJC, Dandapat A, Sekar G. An efficient copper(II)-catalyzed synthesis of benzothiazoles through intramolecular coupling-cyclization of N-(2-chlorophenyl)benzothioamides. Tetrahedron Lett 2010;51:5009–5012.
  • Sathe BS, Jaychandran E, Jagtap VA, Sreenivasa GM. Antitubercular activity of fluoro benzothiazole comprising potent thaizolidinone. Int J Pharma Bio Sci 2010;1:495–500.
  • Choi MM, Kim EA, Hahn HG, Nam KD, Yang SJ, Choi SY et al. Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 2007;239:156–166.
  • Campos J, Núñez C, Díaz JJ, Sánchez RM, Gallo MA, Espinosa A. Anticancer bisquaternary heterocyclic compounds: A ras-ional design. Farmaco 2003;58:221–229.
  • Xie M, Ujjinamatada RK, Sadowska M, Lapidus RG, Edelman MJ, Hosmane RS. A novel, broad-spectrum anticancer compound containing the imidazo[4,5-e][1,3]diazepine ring system. Bioorg Med Chem Lett 2010;20:4386–4389.
  • Bhaskar VH, Mohite PB. Synthesis characterization and evaluation of anticancer activity of some tetrazole derivatives. J Optoelectron Biomed Mater 2010;2:249–259.
  • Menta E, Palumbo M. Novel antineoplastic agents. Exp Opin Ther Patents 1997;7:1401–1426.
  • Dubey R, Shrivastava PK, Basniwal PK, Bhattacharya S, Moorthy NS. 2-(4-aminophenyl) benzothiazole: A potent and selective pharmacophore with novel mechanistic action towards various tumour cell lines. Mini Rev Med Chem 2006;6:633–637.
  • Shi DF, Bradshaw TD, Wrigley S, McCall CJ, Lelieveld P, Fichtner I et al. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996;39:3375–3384.
  • Bradshaw TD, Chua MS, Orr S, Matthews CS, Stevens MF. Mechanisms of acquired resistance to 2-(4-aminophenyl)benzothiazole (CJM 126, NSC 34445). Br J Cancer 2000;83:270–277.
  • Bradshaw TD, Shi DF, Schultz RJ, Paull KD, Kelland L, Wilson A et al. Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo. Br J Cancer 1998;78:421–429.
  • Bradshaw TD, Wrigley S, Shi DF, Schultz RJ, Paull KD, Stevens MF. 2-(4-Aminophenyl)benzothiazoles: Novel agents with selective profiles of in vitro anti-tumour activity. Br J Cancer 1998;77:745–752.
  • Bradshaw TD, Chua MS, Browne HL, Trapani V, Sausville EA, Stevens MF. In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3-methylphenyl)benzothiazoles. Br J Cancer 2002;86:1348–1354.
  • Bradshaw TD, Bibby MC, Double JA, Fichtner I, Cooper PA, Alley MC et al. Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. Mol Cancer Ther 2002;1:239–246.
  • Tuylu BA, Zeytinoglu HS, Isikdag I. Synthesis and mutagenicity of 2-aryl-substitute (o-hydroxy- m-bromo- o-methoxy- o-nitro-phenyl or 4-pyridyl) benzothiazole derivatives on Salmonella typhimurium and human lymphocytes exposed in vitro. Biologia 2007;62:626–632.
  • Choi SJ, Park HJ, Lee SK, Kim SW, Han G, Choo HY. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. Bioorg Med Chem 2006;14:1229–1235.
  • Bhuva HA, Kini SG. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J Mol Graph Model 2010;29:32–37.
  • Lion CJ, Matthews CS, Wells G, Bradshaw TD, Stevens MF, Westwell AD. Antitumour properties of fluorinated benzothiazole-substituted hydroxycyclohexa-2,5-dienones (‘quinols’). Bioorg Med Chem Lett 2006;16:5005–5008.
  • Hutchinson I, Chua MS, Browne HL, Trapani V, Bradshaw TD, Westwell AD et al. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. J Med Chem 2001;44:1446–1455.
  • Hutchinson I, Jennings SA, Vishnuvajjala BR, Westwell AD, Stevens MF. Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. J Med Chem 2002;45:744–747.
  • Hutchinson I, Bradshaw TD, Matthews CS, Stevens MF, Westwell AD. Antitumour benzothiazoles. Part 20: 3′-cyano and 3′-alkynyl-substituted 2-(4′-aminophenyl)benzothiazoles as new potent and selective analogues. Bioorg Med Chem Lett 2003;13:471–474.
  • Zhang L, Fan J, Vu K, Hong K, Le Brazidec JY, Shi J et al. 7′-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitors. J Med Chem 2006;49:5352–5362.
  • Devmurari VP, Pandey S, Goyani MB, Nandanwar RR, Jivani NP, Perumal P. Synthesis and anticancer activity of some novel 2-substituted benzothiazole derivatives. Int J Chem Tech Res 2010;2:681–689.
  • Al-Soud YA, Al-Sadoni HH, Saeed B, Jaber IH, Beni-Khalid MO, Al-Masoudi NA et al. Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives. ARKIVOC 2008;15:225–238.
  • Amnerkar ND, Bhusari KP. Preliminary anticancer activity of some prop-2-eneamido thiazole and 1-acetyl-pyrazolin derivatives of aminobenzothiazoles. Dig J Nano Bio 2010;5:177–184.
  • Schnur RC, Fliri AF, Kajiji S, Pollack VA. N-(5-fluorobenzothiazol-2-yl)-2-guanidinothiazole-4-carboxamide. A novel, systemically active antitumor agent effective against 3LL Lewis lung carcinoma. J Med Chem 1991;34:914–918.
  • Leong CO, Gaskell M, Martin EA, Heydon RT, Farmer PB, Bibby MC et al. Antitumour 2-(4-aminophenyl)benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Br J Cancer 2003;88:470–477.
  • Gupta SD, Moorthy NSHN, Sanyal U. Synthesis cytotoxic evaluation in silico pharmacokinetic and QSAR study of some benzothiazole derivatives. Int J Phar Pharm Sci 2010;2:57–60.
  • Mortimer CG, Wells G, Crochard JP, Stone EL, Bradshaw TD, Stevens MF et al. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. J Med Chem 2006;49:179–185.
  • Repicky A, Jantova S, Cipak L. Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leukemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. Cancer Lett 2009;277:55–63.
  • Racané L, Kralj M, Suman L, Stojkovic R, Tralic-Kulenovic V, Karminski-Zamola G. Novel amidino substituted 2-phenylbenzothiazoles: Synthesis, antitumor evaluation in vitro and acute toxicity testing in vivo. Bioorg Med Chem 2010;18:1038–1044.
  • Trapani G, Franco M, Latrofa A, Reho A, Liso G. Synthesis, in vitro and in vivo cytotoxicity, and prediction of the intestinal absorption of substituted 2-ethoxycarbonyl-imidazo[2,1-b]benzothiazoles. Eur J Pharm Sci 2001;14:209–216.
  • Dong-Fang S, Bradshaw TD, Wrigley S, Mccall CJ, Lelieveld P, Fichtner I et al. Antitumor benzothiazoles 31 Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J Med Chem 1996;39:3375–3384.
  • Shi DF, Bradshaw TD, Chua MS, Westwell AD, Stevens MF. Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives. Bioorg Med Chem Lett 2001;11:1093–1095.
  • Wells G, Bradshaw TD, Diana P, Seaton A, Shi DF, Westwell AD et al. Antitumour benzothiazoles. Part 10: The synthesis and antitumour activity of benzothiazole substituted quinol derivatives. Bioorg Med Chem Lett 2000;10:513–515.
  • Vicini P, Geronikaki A, Incerti M, Busonera B, Poni G, Cabras CA et al. Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. Bioorg Med Chem 2003;11:4785–4789.
  • Yoshida M, Hayakawa I, Hayashi N, Agatsuma T, Oda Y, Tanzawa F et al. Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents. Bioorg Med Chem Lett 2005;15:3328–3332.
  • Shu-Ting H, I-Jen H, Chen C. Synthesis and anticancer evaluation of bis(benzimidazoles) bis(benzoxazoles) and benzothiazoles. Bioorg Med Chem 2006;14:6106–6119.
  • Wan-Ping H, Yin-Kai C, Chao-Cheng L, Hsin-Su Y, Yi-Min T, Shu-Mei H et al. Synthesis and biological evaluation of 2-(4-aminophenyl)benzothiazole derivatives as photosensitizing agents. Bioorg Med Chem 2010;18:6197–6207.
  • Aiello S, Wells G, Stone EL, Kadri H, Bazzi R, Bell DR et al. Synthesis and biological properties of benzothiazole, benzoxazole, and chromen-4-one analogues of the potent antitumor agent 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (PMX 610, NSC 721648). J Med Chem 2008;51:5135–5139.
  • Sharma PC, Jain A, Jain S. Fluoroquinolone antibacterials: A review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 2009;66:587–604.
  • Sharma PC, Alawadhi N, Sharma A, Pahwa R, Rajak H. Fluoroquinolones in urinary tract infections: A study on perception analysis of prescribers. Der Chemica Sinica 2010;1:84–90.
  • Chawla R, Sahoo U, Arora A, Sharma PC, Radhakrishnan V. Microwave assisted synthesis of some novel 2-pyrazoline derivatives as possible antimicrobial agents. Acta Pol Pharm 2010;67:55–61.
  • Mishra R, Tomar I. Pyrimidine: The molecule of diverse biological and medicinal importance. Int J Pharm Sci Res 2011;2:758–771.
  • Gouveia FL, de Oliveira RM, de Oliveira TB, da Silva IM, do Nascimento SC, de Sena KX et al. Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones. Eur J Med Chem 2009;44:2038–2043.
  • Sharma PC, Jain A, Jain S, Pahwa R, Yar MS. Ciprofloxacin: Review on developments in synthetic, analytical, and medicinal aspects. J Enzyme Inhib Med Chem 2010;25:577–589.
  • Bellman R. Clinical pharmacokinetics of systemically administered antimycotics. Curr Clin Pharmacol 2007;2:37–58.
  • Sharma PC, Jain S. Synthesis and in vitro antibacterial activity of some novel N-nicotinyl-1-ethyl-6-flouro-1,4-dihydro-7-piperazine-1-yl-4-oxoquinoline-3-carboxylates. Acta Pol Pharm Drug Res 2008;65:551–586.
  • Mistry KM, Desai KR. Synthesis of novel heterocyclic 4-thiazolidinone derivatives and their antibacterial activity. E J Chem 2004;1:189–193.
  • Rajeeva B, Srinivasulu N, Shantakumar SM. Synthesis and antimicrobial activity of some new 2-substitued benzothiazole derivatives. E J Chem 2009;6:775–779.
  • Kaur H, Kumar S, Singh I, Saxena KK, Kumar A. Synthesis, characterization and biological activity of substituted benzothiazole derivatives. Dig J Nanomater Bios 2010;5:67–76.
  • Sigmundova I, Zahradnik P, Magdolen P, Bujdakova H. Synthesis and study of new antimicrobial benzothiazoles substituted on heterocyclic ring. ARKIVOC 2008;8:183–192.
  • Gajdos P, Magdolen P, Zahradník P, Foltínová P. New conjugated benzothiazole-N-oxides: Synthesis and biological activity. Molecules 2009;14:5382–5388.
  • Pareek PK, Mithlesh, Kriplani P, Ravikant, Ojha KG. Rapid synthesis and biological activities of some new benzothiazol-2-ylhexahydro-s-triazine derivatives. Phosphorus Sulfur and Silicon 2010;185:1338–1345.
  • Nagarajan AS, Kamalraj S, Muthumary J, Reddy BSR. Synthesis of biologically active benzothiazole substituted thiazolidinone derivatives via cyclization of unsymmetrical imine. Indian J Chem 2009;48B:1577–1582.
  • Sidoova E, Loos D, Bujdakova H, Kallova J. New anticandidous 2-alkylthio-6-aminobenzothiazoles. Molecules 1997;2:36–42.
  • Malik JK, Manvi FV, Nanjwade BK, Singh S. Synthesis and screening of some new 2-amino substituted benzothiazole derivatives for antifungal activity. Drug Invention Today 2009;1:32–34.
  • Soni B, Ranawat MS, Sharma R, Bhandari A, Sharma S. Synthesis and evaluation of some new benzothiazole derivatives as potential antimicrobial agents. Eur J Med Chem 2010;45:2938–2942.
  • Latrofa A, Franco M, Lopedota A, Rosato A, Carone D, Vitali C. Structural modifications and antimicrobial activity of N-cycloalkenyl-2-acylalkylidene-2,3-dihydro-1,3-benzothiazoles. Farmaco 2005;60:291–297.
  • Saeed A, Rafique H, Hameed A, Rasheed S. Synthesis and antibacterial activity of some new 1-aroyl-3-(substituted-2-benzothiazolyl)thioureas. Pharm Chem J 2008;42:191–195.
  • Saeed S, Rashid N, Jones PG, Ali M, Hussain R. Synthesis, characterization and biological evaluation of some thiourea derivatives bearing benzothiazole moiety as potential antimicrobial and anticancer agents. Eur J Med Chem 2010;45:1323–1331.
  • Bhusari KP, Amnerkar ND, Khedekar PB, Kale MK, Bhole RP.Synthesis and in vitro antimicrobial activity of some new 4-amino-n-(13-benzothiazol-2-yl)benzenesulphonamide derivatives. Asian J Res Chem 2008;1:23–28.
  • Franchini C, Muraglia M, Corbo F, Florio MA, Di Mola A, Rosato A et al. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity. Arch Pharm (Weinheim) 2009;342:605–613.
  • Bondock S, Fadaly W, Metwally MA. Enaminonitrile in heterocyclic synthesis: Synthesis and antimicrobial evaluation of some new pyrazole, isoxazole and pyrimidine derivatives incorporating a benzothiazole moiety. Eur J Med Chem 2009;44:4813–4818.
  • Sain DK, Thandhaney B, Joshi A, Hussain N, Talesara GL. Synthesis, characterization and biological evaluation of some heterocyclic compounds containing ethoxyphthalimide moiety via key intermediate 6-chloro 1,3-benzothiazole 2-amine. Indian J Chem 2010;49B:818–825.
  • Baheti KG, Jadhav JS, Suryavanshi AT, Kuberkar SV. Novel synthesis and antibacterial activity of 1,5-iminobenzothiazolo[2,3-b]pyrimido[5,6-c]pyrimido[2,3-b]benzothiazole-14(H)-one and its 310 disubstituted derivatives. Indian J Chem 2005;44B:834–837.
  • Gupta S, Ajmera N, Gautam N, Sharma R, Gautam DC. Novel synthesis and biological activity of pyrimido[2,3-b]benzothiazoles. Indian J Chem 2009;48B:853–857.
  • Vedavathi M, Somashekar B, Sreenivasa GM, Jayachandran E. Synthesis, characterization and antimicrobial activity of fluorobenzothiazole incorporated with 1,3,4-thiadiazole. J Pharm Sci Res 2010;2:53–63.
  • Kuchta T, Léka C, Farkas P, Bujdáková H, Belajová E, Russell NJ. Inhibition of sterol 4-demethylation in Candida albicans by 6-amino-2-n-pentylthiobenzothiazole, a novel mechanism of action for an antifungal agent. Antimicrob Agents Chemother 1995;39:1538–1541.
  • Lakhan R, Ral BJ. Synthesis of some new 3-(2-benzothiazolyl)-4(3H)-quinazoliones as antifungal agents. J Chem Eng Data 1986;31:501–502.
  • Huang W, Yang GF. Microwave-assisted, one-pot syntheses and fungicidal activity of polyfluorinated 2-benzylthiobenzothiazoles. Bioorg Med Chem 2006;14:8280–8285.
  • Mithlesh, Pareek PK, Kant R, Shukla SK, Ojha KG. Rapid synthesis and biological evaluation of 1,4 dihydropyridine derivatives containing a benzothiazolyl moiety. Cent Eur J Chem 2010;8:163–173.
  • Sharma V, Sharma KV. Synthesis and biological activity of some 3,5-diaryl-1-benzothiazolopyrazoline derivatives: Reaction of chalcone with 2-hydrazinobenzothiazoles. E J Chem 2009;6:348–356.
  • Argyropoulou I, Geronikaki A, Vicini P, Zani F. Synthesis and biological evaluation of sulfonamide thiazole and benzothiazole derivatives as antimicrobial agents. ARKIVOC 2009;6:89–102.
  • Alang G, Kaur R, Kaur G. Synthesis and antibacterial activity of some new benzothiazole derivatives. Acta Pharm Sci 2010;52:213–218.
  • Alang G, Kaur R, Singh A, Budhlakoti P, Singh A, Sanwal R. Synthesis, characterization and antifungal activity of certain(e)-1-(1-(substitutedphenyl)ethylidene)-2-(6-methylbenzo[d]thiazol-2-yl) hydrazine analogues. IJPBA 2010;1:56–61.
  • Chaitanya MS, Nagendrappa G, Vaidya VP. Synthesis, biological and pharmacological activities of 2-methyl-4H-pyrimido[2,1-b][1,3]benzothiazoles. J Chem Pharm Res 2010;2:206–213.
  • Sharma PC, Sharma OP, Vasudeva N, Mishra DN, Singh SK. Anti-HIV substances of natural origin-An updated account. Natural Product Radiance 2006;5:70–77.
  • Kakkar S, Mohanraj K, Sharma PC. Simple and rapid RP-HPLC method to determine the purity of the antiretroviral drug Lamivudine. Lat Am J Pharm 2010;29:1075–1081.
  • Kharb R, Shahar Yar M, Sharma PC. Recent advances and future perspectives of triazole analogs as promising antiviral agents. Mini Rev Med Chem 2011;11:84–96.
  • Yi-Sheng X, Cheng-Chu Z, Zi-Guo J, Li-Ming H, Ru-gang Z. Design, synthesis and anti-HIV integrase evaluation of 4-oxo- 4h-quinolizine-3-carboxylic acid derivatives. Molecules 2009;14:868–883.
  • De CE. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present and future. Chem Biodiversity 2004;1 44.
  • Ellis D, Kuhen KL, Anaclerio B, Wu B, Wolff K, Yin H et al. Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem Lett 2006;16:4246–4251.
  • Akhtar T, Hameed S, Al-Masoudi NA, Loddo R, La Colla P. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives. Acta Pharm 2008;58:135–149.
  • Akbay A, Oren I, Temiz-Arpaci O, Aki-Sener E, Yalcin I. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole benzimidazole benzothiazole and oxazolo(4,5-b)pridine derivatives. Arzneim-forsch/Drug Res 2003;4:266–271.
  • Nagarajan SR, De Crescenzo GA, Getman DP, Lu HF, Sikorski JA, Walker JL et al. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. Bioorg Med Chem 2003;11:4769–4777.
  • Pudhom K, Kasai K, Terauchi H, Inoue H, Kaiser M, Brun R et al. Synthesis of three classes of rhodacyanine dyes and evaluation of their in vitro and in vivo antimalarial activity. Bioorg Med Chem 2006;14:8550–8563.
  • Seebacher W, Brun R, Weis R. New 4-aminobicyclo[2.2.2]octane derivatives and their activities against Plasmodium falciparum and Trypanosoma b. rhodesiense. Eur J Pharm Sci 2004;21:225–233.
  • Friedman MD, Stotter PL, Porter TH, Folkers K. Synthesis of alkyl-4,7-dioxobenzothiazoles with prophylactic antimalarial activity. J Med Chem 1973;16:1314–1316.
  • Burger A, Sawhney SN. Antimalarials 111 Benzothiazole amino alcohols. Antimalarials 11:270–272.
  • Bowyer PW, Gunaratne RS, Grainger M, Withers-Martinez C, Wickramsinghe SR, Tate EW et al. Molecules incorporating a benzothiazole core scaffold inhibit the N-myristoyltransferase of Plasmodium falciparum. Biochem J 2007;408:173–180.
  • Kharb R, Yar MS, Sharma PC. New insights into chemistry and anti-infective potential of triazole scaffold. Curr Med Chem 2011;18:3265–3297.
  • Karali N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Ozbey S et al. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. Bioorg Med Chem 2007;15:5888–5904.
  • Aridoss G, Amirthaganesan S, Kim MS, Kim JT, Jeong YT. Synthesis, spectral and biological evaluation of some new thiazolidinones and thiazoles based on t-3-alkyl-r-2,c-6-diarylpiperidin-4-ones. Eur J Med Chem 2009;44:4199–4210.
  • Kolavi G, Hegde V, Khazi I, Gadad P. Synthesis and evaluation of antitubercular activity of imidazo[2,1-b][1,3,4]thiadiazole derivatives. Bioorg Med Chem 2006;14:3069–3080.
  • Dinakaran M, Senthilkumar P, Yogeeswari P, Sriram D. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis. Biomed Pharmacother 2009;63:11–18.
  • Huang Q, Mao J, Wan B, Wang Y, Brun R, Franzblau SG et al. Searching for new cures for tuberculosis: Design, synthesis, and biological evaluation of 2-methylbenzothiazoles. J Med Chem 2009;52:6757–6767.
  • Palmer PJ, Trigg RB, Warrington JV. Benzothiazolines as antituberculous agents. J Med Chem 1971;14:248–251.
  • Geary TG, Woo K, McCarthy JS, Mackenzie CD, Horton J, Prichard RK et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 2010;40:1–13.
  • Abuzar S, Sharma S, Fatma N, Gupta S, Murthy PK, Katiyar JC et al. Studies in potential filaricides. 18. Synthesis of 2,2′-disubstituted 5,5′-dibenzimidazolyl ketones and related compounds as potential anthelmintics. J Med Chem 1986;29:1296–1299.
  • Sreenivasa GM, Jayachandran E, Shivakumar B, Jayaraj KK, Kumar Vijay MMJ. Synthesis of bioactive molecule fluoro benzothiazole comprising potent heterocyclic moieties for anthelmentic activity. Arch Pharm Sci Res 2009;1:150–157.
  • Nadkarni AB, Vijayalaxmi KR, Khadse GB.Synthesis and anthelmintic activity of substituted phenyl imidazo [2,1-b]benzothiazoles. Indian J Heterocycl Chem 2000;9:309–310.
  • Kumar V, Sharma A, Sharma PC. Synthesis of some novel 2,5-disubstituted thiazolidinones from a long chain fatty acid as possible anti-inflammatory, analgesic and hydrogen peroxide scavenging agents. J Enzyme Inhib Med Chem 2011;26:198–203.
  • Sharma PC, Kaur G, Pahwa R, Sharma A, Rajak H. Quinazolinone analogs as potential therapeutic agents. Curr Med Chem 2011;18:4786–4812.
  • Verma A, Saraf SK. 4-thiazolidinone–a biologically active scaffold. Eur J Med Chem 2008;43:897–905.
  • Sondhi SM, Singhal N, Johar M, Reddy BS, Lown JW. Heterocyclic compounds as inflammation inhibitors. Curr Med Chem 2002;9:1045–1074.
  • Geronikaki AA, Lagunin AA, Hadjipavlou-Litina DI, Eleftheriou PT, Filimonov DA, Poroikov VV et al. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. J Med Chem 2008;51:1601–1609.
  • Giria RS, Thakerb HM, Giordanoc T, Williamsc J, Rogersc D, Sudersanamb V et al. Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-κB and AP-1 mediated transcription activation and as potential antiinflammatory agents. Eur J Med Chem 2009;44:2184–2189.
  • Sharma PC, Yadav S, Pahwa R, Kaushik D, Jain S. Synthesis and evaluation of novel prodrugs of naproxen. Med Chem Res 2011;20:648–655.
  • Papadopoulou C, Geronikaki A, Hadjipavlou-Litina D. Synthesis and biological evaluation of new thiazolyl/benzothiazolyl-amides, derivatives of 4-phenyl-piperazine. Farmaco 2005;60:969–973.
  • Aakashdeep, Jain S, Sharma PC. Synthesis and antiinflammatory activity of some novel biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazoldin-3-yl amides. Acta Pol Pharm Drug Res 2010;67:63–67.
  • Gaba M, Singh D, Singh S, Sharma V, Gaba P. Synthesis and pharmacological evaluation of novel 5-substituted-1-(phenylsulfonyl)-2-methylbenzimidazole derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem 2010;45:2245–2249.
  • Paramashivappa R, Phani Kumar P, Subba Rao PV, Srinivasa Rao A. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg Med Chem Lett 2003;13:657–660.
  • Singh HP, Sharma CS, Gautam CP.Synthesis and pharmacological screening of some novel 2-arylhydrazino and 2-aryloxy-pyrimido [2,1-b] benzothiazole derivatives. American-Eurasian J Scientific Res 2009;4:222–228.
  • Venkatesh P, Pandeya SN. Synthesis, characterisation and antiinflammatory activity of some 2-amino benzothiazole derivatives. Int J Chem Tech Res 2009;1:1354–1358.
  • Wada J, Suzuki T, Iwasaki M, Miyamatsu H, Ueno S, Shimizu M. A new nonsteroidal antiinflammatory agent. 2-Substituted 5- or 6-benzothiazoleacetic acids and their derivatives. J Med Chem 1973;16:930–934.
  • Musser JH, Kubrak DM, Chang J, DiZio SM, Hite M, Hand JM et al. Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid esters. J Med Chem 1987;30:400–405.
  • Cheng-Xi W, Wu D, Zhi-Gang S, Kyu-Yun C, Zhe-Shan Q. Synthesis of 6-(3-substituted-4H-1,2,4-triazol-4-yl)-2-phenylbenzo[d]oxazoles as potential anticonvulsant agents. Med Chem Res 2010;19:925–935.
  • Amin KM, Rahman DE, Al-Eryani YA. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorg Med Chem 2008;16:5377–5388.
  • Amnerkar ND, Bhusari KP. Synthesis, anticonvulsant activity and 3D-QSAR study of some prop-2-eneamido and 1-acetyl-pyrazolin derivatives of aminobenzothiazole. Eur J Med Chem 2010;45:149–159.
  • Sharma PP, Pandeya SN, Roy RK, Verma AK, Gupta S. Synthesis and anticonvulsant activity of some novel isatin schiff’s bases. Int J Chem Tech Res 2009;1:758–763.
  • Rana A, Siddiqui N, Khan SA, Ehtaishamul Haque S, Bhat MA. N-{[(6-substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: Synthesis and pharmacological evaluation. Eur J Med Chem 2008;43:1114–1122.
  • Siddiqui N, Rana A, Khan SA, Bhat MA, Haque SE. Synthesis of benzothiazole semicarbazones as novel anticonvulsants–the role of hydrophobic domain. Bioorg Med Chem Lett 2007;17:4178–4182.
  • Mishra MK, Ray D, Barik BB. Microcapsules and transdermal patch: A comparative approach for improved delivery of antidiabetic drug. AAPS PharmSciTech 2009;10:928–934.
  • Tripathi BK, Srivastava AK. Diabetes mellitus: Complications and therapeutics. Med Sci Monit 2006;12:RA130–RA147.
  • Mohan V, Madan Z, Jha R, Deepa R, Pradeepa R. Diabetes- social and economic perspectives in the new millennium. Int J Diab Dev Countries 2004;24:29–35.
  • Pattan SR, Suresh Pujar VD, Reedy VVK, Rasal VP, Koti BC. Synthesis and antidiabetic activity of 2-amino[5′(4-sulphonylbenzylidine)-2,4-thiazolidinedione]-7-chloro-6-fluorobenzothiazole. Indian J Chem 2005;44B:2404–2408.
  • De SK, Chen LH, Stebbins JL, Machleidt T, Riel-Mehan M, Dahl R et al. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors. Bioorg Med Chem 2009;17:2712–2717.
  • Van Zandt MC, Jones ML, Gunn DE, Geraci LS, Jones JH, Sawicki DR et al. Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J Med Chem 2005;48:3141–3152.
  • Su X, Vicker N, Ganeshapillai D, Smith A, Purohit A, Reed MJ et al. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Mol Cell Endocrinol 2006;248:214–217.
  • Yar MS, Ansari ZH. Synthesis and in vivo diuretic activity of biphenyl benzothiazole-2-carboxamide derivatives. Acta Pol Pharm Drug Res 2009;66:387–392.
  • Yoshino K, Kohno T, Uno T, Morita T, Tsukamoto G. Organic phosphorus compounds. 1. 4-(Benzothiazol-2-yl)benzylphosphonate as potent calcium antagonistic vasodilator. J Med Chem 1986;29:820–825.
  • Vu CB, Milne JC, Carney DP, Song J, Choy W, Lambert PD et al. Discovery of benzothiazole derivatives as efficacious and enterocyte-specific MTP inhibitors. Bioorg Med Chem Lett 2009;19:1416–1420.
  • Cressier D, Prouillac C, Hernandez P, Amourette C, Diserbo M, Lion C et al. Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles. Bioorg Med Chem 2009;17:5275–5284.
  • Karali N, Güzel O, Ozsoy N, Ozbey S, Salman A. Synthesis of new spiroindolinones incorporating a benzothiazole moiety as antioxidant agents. Eur J Med Chem 2010;45:1068–1077.
  • Costanzo MJ, Yabut SC, Almond HR Jr, Andrade-Gordon P, Corcoran TW, De Garavilla L et al. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. J Med Chem 2003;46:3865–3876.
  • Laddha SS, Wadodkar SG, Meghal SK. cAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6,8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H]-quinazolinone. Med Chem Res 2009;18:268–276.
  • Wade JJ, Toso CB, Matson CJ, Stelzer VL. Synthesis and antiallergic activity of some acidic derivatives of 4H-pyrimido[2,1-b]benzazol-4-ones. J Med Chem 1983;26:608–611.
  • Chitra V, Kumar PK. Neuroprotective studies of rubia cordifolia linn on β-amyloid induced cognitive dysfunction in mice. Int J Pharm Tech Res 2009;1:1000–1009.
  • Majo VJ, Prabhakaran J, Mann JJ, Kumar JSD. An efficient palladium catalyzed synthesis of 2-arylbenzothiazoles. Tetrahedron Lett 2003;44:8535–8537.
  • Byeon SR, Jin YJ, Lim SJ, Lee JH, Yoo KH, Shin KJ et al. Ferulic acid and benzothiazole dimer derivatives with high binding affinity to beta-amyloid fibrils. Bioorg Med Chem Lett 2007;17:4022–4025.
  • Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–181.
  • Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336–4350.
  • Supuran CT, Fiore AD, Alterio V, Monti SM, Simone GD. Recent advances in structural studies of the carbonic anhydrase family: The crystal structure of human CA IX and CA XIII. Curr Pharm Des 2010;16:3346–3254.
  • Supuran CT. Carbonic anhydrases as drug targets–an overview. Curr Top Med Chem 2007;7:825–833.
  • Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003;23:146–189.
  • Supuran CT. Carbonic anhydrase inhibition with natural products: Novel chemotypes and inhibition mechanisms. Mol Divers 2011;15:305–316.
  • Winum JY, Scozzafava A, Montero JL, Supuran CT. Metal binding functions in the design of carbonic anhydrase inhibitors. Curr Top Med Chem 2007;7:835–848.
  • Winum JY, Scozzafava A, Montero JL, Supuran CT. Design of zinc binding functions for carbonic anhydrase inhibitors. Curr Pharm Des 2008;14:615–621.
  • Winum JY, Scozzafava A, Montero JL, Supuran CT. New zinc binding motifs in the design of selective carbonic anhydrase inhibitors. Mini Rev Med Chem 2006;6:921–936.
  • Winum JY, Scozzafava A, Montero JL, Supuran CT. Sulfamates and their therapeutic potential. Med Res Rev 2005;25:186–228.
  • Scozzafava A, Mastrolorenzo A, Supuran CT. Carbonic anhydrase inhibitors and activators and their use in therapy. Expert Opin Ther Patents 2006;16:1627–1664.
  • Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199–229.
  • Di Fiore A, Scozzafava A, Winum JY, Montero JL, Pedone C, Supuran CT et al. Carbonic anhydrase inhibitors: Binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties. Bioorg Med Chem Lett 2007;17:1726–1731.
  • Baranauskiene L, Matulis D. Intrinsic thermodynamics of ethoxzolamide inhibitor binding to human carbonic anhydrase XIII. BMC Biophys 2012;5:12.
  • Di Fiore A, Pedone C, Antel J, Waldeck H, Witte A, Wurl M et al. Carbonic anhydrase inhibitors: The X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Bioorg Med Chem Lett 2008;18:2669–2674.
  • Scheetz ME II, Carlson DG, Schinitsky MR. Frentizole, a novel immunosuppressive, and azathioprine: Their comparative effects on host resistance to Pseudomonas aeruginosa, Candida albicans, herpes simplex virus, and influenza (Ann Arbor) virus. Infect Immun 1977;15:145–148.
  • Shi-Wei C, Ze-Rong L, Xiang-Yuan L. Prediction of antifungal activity by support vector machine approach. J Mol Struc Theochem 2005;731:73–81.
  • Arakawa R, Ito H, Takano A, Okumura M, Takahashi H, Takano H et al. Dopamine D2 receptor occupancy by perospirone: A positron emission tomography study in patients with schizophrenia and healthy subjects. Psychopharmacology (Berl) 2010;209:285–290.
  • Fichtner I, Monks A, Hose C, Stevens MF, Bradshaw TD. The experimental antitumor agents Phortress and doxorubicin are equiactive against human-derived breast carcinoma xenograft models. Breast Cancer Res Treat 2004;87:97–107.
  • Vinodhini C, Sravani MVND, Bhanuprakash M, Devi MS, Imran M, Osman MOA et al. Method development and validation of pramipexole dihydrochloride monohydrate in tablet dosage form by uv and visible spectrophotometric methods. Int J Res Phar Biomed Sci 2011;2:680–686.
  • Jain A, Sharma R, Gahalain N. Anxiety disorder: An overview. Int J Pharmacy Life Sci 2010;1:396–409.
  • Satyanarayana B, Saravanan M, Kumari KS, Lokamaheshwari DP, Sridhar Ravishankar R, Nageswari A et al. Synthesis and spectral characterization of related compounds of riluzole an amyotrophic lateral sclerosis drug substance. ARKIVOC 2008;14:109–114.
  • Voropai ES, Samtsov MP, Kaplevskii KN, Maskevich AA, Stepuro VI, Povarova OI et al. Spectral properties of thioflavin-t and its complexes with amyloid fibrils. J Appl Spectros 2003;70:868–874.
  • Tanaka R, Kawamura T, Hirayama N. Structure of tiaramide. Anal Sci 2007;23:105–106.
  • Ding Q, Huang XG, Wu J. Facile synthesis of benzothiazoles via cascade reactions of 2-iodoanilines, acid chlorides and Lawesson’s reagent. J Comb Chem 2009;11:1047–1049.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.